Nuveen LLC Makes New $437,000 Investment in Nature’s Sunshine Products, Inc. $NATR

Nuveen LLC bought a new position in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 34,831 shares of the company’s stock, valued at approximately $437,000. Nuveen LLC owned 0.19% of Nature’s Sunshine Products as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. GAMMA Investing LLC increased its stake in shares of Nature’s Sunshine Products by 2,090.2% in the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company’s stock worth $28,000 after acquiring an additional 2,132 shares during the period. Deutsche Bank AG acquired a new stake in shares of Nature’s Sunshine Products in the fourth quarter worth $103,000. Wells Fargo & Company MN increased its stake in shares of Nature’s Sunshine Products by 28.8% in the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company’s stock worth $106,000 after acquiring an additional 1,611 shares during the period. BNP Paribas Financial Markets increased its stake in shares of Nature’s Sunshine Products by 346.9% in the fourth quarter. BNP Paribas Financial Markets now owns 11,719 shares of the company’s stock worth $172,000 after acquiring an additional 9,097 shares during the period. Finally, Bridgeway Capital Management LLC increased its stake in shares of Nature’s Sunshine Products by 24.1% in the fourth quarter. Bridgeway Capital Management LLC now owns 17,514 shares of the company’s stock worth $257,000 after acquiring an additional 3,400 shares during the period. Institutional investors and hedge funds own 79.40% of the company’s stock.

Nature’s Sunshine Products Price Performance

Nature’s Sunshine Products stock opened at $17.34 on Friday. The stock has a market capitalization of $305.88 million, a PE ratio of 23.43 and a beta of 1.11. Nature’s Sunshine Products, Inc. has a 12 month low of $11.01 and a 12 month high of $18.06. The business has a 50 day simple moving average of $15.73 and a 200-day simple moving average of $14.26.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.19. The business had revenue of $114.75 million during the quarter, compared to analysts’ expectations of $113.10 million. Nature’s Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.

Analyst Upgrades and Downgrades

NATR has been the topic of a number of research reports. Canaccord Genuity Group increased their price objective on shares of Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. DA Davidson reiterated a “buy” rating and issued a $19.00 price objective on shares of Nature’s Sunshine Products in a research note on Tuesday, June 3rd. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $19.67.

Insider Activity at Nature’s Sunshine Products

In other Nature’s Sunshine Products news, EVP Nathan G. Brower sold 9,996 shares of the stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $16.54, for a total transaction of $165,333.84. Following the transaction, the executive vice president directly owned 48,277 shares of the company’s stock, valued at $798,501.58. This trade represents a 17.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the stock in a transaction on Friday, June 27th. The shares were sold at an average price of $11.46, for a total transaction of $32,713,796.22. The disclosure for this sale can be found here. In the last three months, insiders sold 2,879,275 shares of company stock valued at $33,123,599. 4.70% of the stock is currently owned by company insiders.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.